ACILX
Price
$28.87
Change
+$0.34 (+1.19%)
Updated
Jul 6 closing price
Net Assets
5.59B
JDMAX
Price
$144.68
Change
+$0.18 (+0.12%)
Updated
Jul 6 closing price
Net Assets
22.28B
Interact to see
Advertisement

ACILX vs JDMAX

ACILX vs JDMAX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JDMAX has more cash in the bank: 22.3B vs. ACILX (5.59B). ACILX (0.00) and JDMAX (0.00) have matching dividends . ACILX was incepted earlier than JDMAX: ACILX (4 years) vs JDMAX (17 years). JDMAX (1.14) is less costly to investors than ACILX (0.65). ACILX is a more actively managed with annual turnover of: 62.00 vs. JDMAX (17.00). ACILX has a lower initial minimum investment than JDMAX: ACILX (0) vs JDMAX (2500). JDMAX annual gain was more profitable for investors over the last year : 3.63 vs. ACILX (-10.98).
ACILXJDMAXACILX / JDMAX
Total Expense Ratio0.001.14-
Annual Report Gross Expense Ratio0.651.1457%
Fund Existence4 years17 years-
Gain YTD7.9468.78290%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets5.59B22.3B25%
Annual Yield % from dividends0.000.00-
Returns for 1 year-10.983.63-302%
Returns for 3 years18.8814.29132%
Returns for 5 yearsN/A-13.58-
Returns for 10 yearsN/A60.16-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUST1.160.06
+5.45%
Austin Gold Corp
KRRO14.00N/A
N/A
Korro Bio
AXON597.04N/A
N/A
Axon Enterprise
AVTX18.84N/A
N/A
Avalo Therapeutics
OTF10.37-0.09
-0.86%
Blue Owl Technology Fin Corp